Keeping up with health and wellness news from Comoros

Provided by AGP

Healthcare Brief Comoros
Got News to Share?
Got News to Share? Explore more publications!

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 6, 2026

Where Executives Are Doubling Down on Their Companies’ Fortunes
May. 6, 2026

Where Executives Are Doubling Down on Their Companies’ Fortunes

Indeterminate GlobeNewswire
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
May. 6, 2026

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

Indeterminate GlobeNewswire
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
May. 6, 2026

Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101

Indeterminate GlobeNewswire
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May. 6, 2026

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Indeterminate GlobeNewswire
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
May. 6, 2026

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

Indeterminate GlobeNewswire
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
May. 6, 2026

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

Indeterminate GlobeNewswire
Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division
May. 6, 2026

Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division

Indeterminate GlobeNewswire
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
May. 6, 2026

Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

Indeterminate GlobeNewswire
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
May. 6, 2026

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

Indeterminate GlobeNewswire
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
May. 6, 2026

CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference

Indeterminate GlobeNewswire
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May. 6, 2026

InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares

Indeterminate GlobeNewswire
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May. 6, 2026

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases

Indeterminate GlobeNewswire
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
May. 6, 2026

SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041

Indeterminate GlobeNewswire
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May. 6, 2026

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

Indeterminate GlobeNewswire
Aktis Oncology to Present at the BofA Securities Health Care Conference
May. 6, 2026

Aktis Oncology to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire
ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors
May. 6, 2026

ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors

Indeterminate GlobeNewswire
Annexon to Present at the Bank of America Securities Health Care Conference 2026
May. 6, 2026

Annexon to Present at the Bank of America Securities Health Care Conference 2026

Indeterminate GlobeNewswire
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
May. 6, 2026

IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences

Indeterminate GlobeNewswire
Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform
May. 6, 2026

Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform

Indeterminate GlobeNewswire
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
May. 6, 2026

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Healthcare Brief Comoros

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.